Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
暂无分享,去创建一个
L. Rangell | F.J. Sauvage | F. D. de Sauvage | H. Steinmetz | M. Moore | S. Bunting | S. Bunting | K. Carver-Moore | G. Keller | R. Widmer | T. Lipari | Hope Steinmetz | Linda Rangell | F. J. Sauvage
[1] R. Nishinakamura,et al. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. , 1996, Blood.
[2] K. Kaushansky,et al. Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis. , 1996, Blood.
[3] H. Broxmeyer,et al. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. , 1996, Blood.
[4] B. Druker,et al. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. , 1996, Blood.
[5] S. Orkin,et al. The transcriptional control of hematopoiesis. , 1996, Blood.
[6] M. Brizzi,et al. Effects of recombinant human megakaryocyte growth and development factor on platelet activation. , 1996, Blood.
[7] A. Gurney,et al. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. , 1996, Blood.
[8] W S Alexander,et al. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. , 1996, Blood.
[9] S. Hanson,et al. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. , 1996, Blood.
[10] F. D. de Sauvage,et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin , 1996, The Journal of experimental medicine.
[11] W. Vainchenker,et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. , 1995, Blood.
[12] K. Kaushansky. Thrombopoietin the primary regulator of platelet production. , 1995, Trends in endocrinology and metabolism: TEM.
[13] S. Orkin,et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development , 1995, Cell.
[14] V. Broudy,et al. Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] V. Broudy,et al. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. , 1995, Blood.
[16] M. Hokom,et al. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. , 1995, Blood.
[17] R. Schreiber,et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. , 1994, Blood.
[18] A. Gurney,et al. Thrombocytopenia in c-mpl-deficient mice. , 1994, Science.
[19] M. C. Hu,et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI , 1994, Cell.
[20] V. Broudy,et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin , 1994, Nature.
[21] Scott R. Presnell,et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo , 1994, Nature.
[22] William Vainchenker,et al. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis , 1994, Nature.
[23] D. Goeddel,et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.
[24] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[25] G. Ciliberto,et al. Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.
[26] R. Hoffman,et al. Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. , 1992, Blood.
[27] R. Hoffman,et al. Regulation of megakaryocytopoiesis. , 1989, Blood.
[28] R. Swank,et al. Cocoa: a new mouse model for platelet storage pool deficiency , 1988, British journal of haematology.
[29] J. George,et al. Incorporation of a circulating protein into megakaryocyte and platelet granules. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[30] Rao Ak,et al. Evaluation of platelet function. , 1986 .
[31] U. Landegren. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. , 1984, Journal of immunological methods.
[32] F.J. Sauvage,et al. Genetic Manipulation of Mpl Ligand and Thrombopoietin In Vivo , 1997 .
[33] W. Sheridan,et al. Thrombopoiesis and Thrombopoietins Molecular, Cellular, Preclinical, and Clinical Biology , 1997 .
[34] M. Hokom,et al. Recombinant human megakaryocyte growth and development factor (rhumgdf), a ligand for c‐mpl, produces functional human platelets in vitro , 1995, Stem cells.
[35] R. Swank,et al. Platelet storage pool deficiency associated with inherited abnormalities of the inner ear in the mouse pigment mutants muted and mocha. , 1991, Blood.
[36] A. Rao,et al. Evaluation of platelet function. , 1986, Seminars in hematology.